Harmony Biosciences Holdings, Inc.
NASDAQ:HRMY
32.72 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 201.267 | 186.038 | 172.814 | 154.615 | 168.412 | 160.268 | 134.216 | 119.126 | 128.308 | 117.206 | 107.028 | 85.313 | 91.213 | 80.732 | 73.821 | 59.674 | 56.288 | 45.609 | 38.005 | 19.84 | 5.995 | 0 | 0 | 0 |
| Cost of Revenue
| 54.409 | 42.778 | 38.105 | 33.445 | 43.152 | 32.296 | 25.008 | 20.78 | 26.885 | 22.959 | 18.921 | 14.716 | 17.817 | 14.604 | 12.687 | 10.409 | 9.918 | 7.89 | 6.456 | 3.474 | 1.577 | 0 | 0 | 0 |
| Gross Profit
| 146.858 | 143.26 | 134.709 | 121.17 | 125.26 | 127.972 | 109.208 | 98.346 | 101.423 | 94.247 | 88.107 | 70.597 | 73.396 | 66.128 | 61.134 | 49.265 | 46.37 | 37.719 | 31.549 | 16.366 | 4.418 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.73 | 0.77 | 0.78 | 0.784 | 0.744 | 0.798 | 0.814 | 0.826 | 0.79 | 0.804 | 0.823 | 0.828 | 0.805 | 0.819 | 0.828 | 0.826 | 0.824 | 0.827 | 0.83 | 0.825 | 0.737 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 34.666 | 25.387 | 63.583 | 22.189 | 30.306 | 17.499 | 14.969 | 13.289 | 10.092 | 40.548 | 12.668 | 7.578 | 7.451 | 11.739 | 6.498 | 4.679 | 7.618 | 4.23 | 4.169 | 3.431 | 7.276 | 4.336 | 4.993 | 52.99 |
| General & Administrative Expenses
| 28.865 | 28.587 | 27.224 | 25.676 | 27.872 | 22.546 | 22.809 | 22.062 | 22.643 | 21.331 | 22.163 | 17.88 | 18.205 | 16.856 | 14.302 | 14.547 | 13.466 | 10.508 | 7.628 | 9.29 | 13.994 | 12.56 | 5.892 | 3.962 |
| Selling & Marketing Expenses
| 27.6 | 27.576 | 28.507 | 27.233 | 26.886 | 23.418 | 24.528 | 22.572 | 21.075 | 20.467 | 20.16 | 17.583 | 19.109 | 16.48 | 17.022 | 15.506 | 17.526 | 12.601 | 12.443 | 13.254 | 16.841 | 12.908 | 8.378 | 6.191 |
| SG&A
| 56.465 | 56.163 | 49.77 | 46.948 | 54.758 | 45.964 | 47.337 | 44.634 | 43.718 | 41.798 | 42.323 | 35.463 | 37.314 | 33.336 | 31.324 | 30.053 | 30.992 | 23.109 | 20.071 | 22.544 | 30.835 | 25.468 | 14.27 | 10.153 |
| Other Expenses
| 0 | 0 | 0.037 | -0.141 | 0.193 | -0.005 | -0.031 | 0.002 | 0.073 | 0.056 | 0.042 | -0.002 | 0.031 | 0 | 0.004 | -0.02 | 0 | -1.525 | -0.4 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 91.131 | 81.55 | 113.353 | 69.137 | 85.064 | 63.463 | 62.306 | 57.923 | 53.81 | 82.346 | 54.991 | 43.041 | 44.765 | 45.075 | 37.822 | 34.732 | 38.61 | 27.339 | 24.24 | 25.975 | 38.111 | 29.804 | 19.263 | 63.143 |
| Operating Income
| 55.727 | 61.71 | 21.356 | 52.033 | 40.196 | 64.509 | 46.902 | 40.423 | 47.613 | 11.901 | 33.116 | 27.556 | 28.631 | 21.053 | 23.312 | 14.533 | 7.76 | 10.38 | 7.309 | -9.609 | -33.693 | -29.804 | -19.263 | -63.143 |
| Operating Income Ratio
| 0.277 | 0.332 | 0.124 | 0.337 | 0.239 | 0.403 | 0.349 | 0.339 | 0.371 | 0.102 | 0.309 | 0.323 | 0.314 | 0.261 | 0.316 | 0.244 | 0.138 | 0.228 | 0.192 | -0.484 | -5.62 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.428 | 0.46 | 0.338 | -0.248 | -0.507 | -12.677 | -2.807 | -2.643 | -3.51 | -3.934 | -3.885 | -4.171 | -4.156 | -31.575 | -7.223 | -7.147 | -7.966 | -8.471 | -7.336 | -29.011 | -2.747 | -2.095 | -1.353 | 0.122 |
| Income Before Tax
| 56.155 | 62.17 | 21.694 | 51.785 | 39.689 | 51.832 | 44.095 | 37.78 | 44.103 | 7.967 | 29.231 | 23.385 | 24.475 | -10.522 | 16.089 | 7.386 | -0.206 | 1.909 | -0.027 | -38.62 | -36.44 | -31.899 | -20.616 | -63.021 |
| Income Before Tax Ratio
| 0.279 | 0.334 | 0.126 | 0.335 | 0.236 | 0.323 | 0.329 | 0.317 | 0.344 | 0.068 | 0.273 | 0.274 | 0.268 | -0.13 | 0.218 | 0.124 | -0.004 | 0.042 | -0.001 | -1.947 | -6.078 | 0 | 0 | 0 |
| Income Tax Expense
| 6.68 | 16.077 | 10.103 | 13.451 | 13.082 | 13.371 | 9.795 | 8.295 | -4.406 | -79.976 | 5.7 | 1.9 | 1.761 | -0.902 | 1.972 | 7.127 | -4.383 | 5.421 | 6.936 | 29.011 | 0 | 0 | 0 | 0 |
| Net Income
| 49.475 | 46.093 | 11.591 | 38.334 | 26.607 | 38.461 | 34.3 | 29.485 | 48.509 | 87.943 | 23.531 | 21.485 | 22.714 | -9.62 | 14.117 | 7.386 | -0.206 | 1.909 | -0.027 | -38.62 | -36.44 | -31.899 | -20.616 | -63.021 |
| Net Income Ratio
| 0.246 | 0.248 | 0.067 | 0.248 | 0.158 | 0.24 | 0.256 | 0.248 | 0.378 | 0.75 | 0.22 | 0.252 | 0.249 | -0.119 | 0.191 | 0.124 | -0.004 | 0.042 | -0.001 | -1.947 | -6.078 | 0 | 0 | 0 |
| EPS
| 0.87 | 0.81 | 0.2 | 0.68 | 0.46 | 0.64 | 0.57 | 0.49 | 0.82 | 1.48 | 0.4 | 0.36 | 0.39 | -0.17 | 0.25 | 0.13 | -0.004 | -0.14 | -0 | -0.7 | -0.66 | -0.58 | -0.37 | -1.14 |
| EPS Diluted
| 0.85 | 0.79 | 0.2 | 0.67 | 0.45 | 0.63 | 0.56 | 0.48 | 0.79 | 1.44 | 0.39 | 0.35 | 0.38 | -0.17 | 0.24 | 0.13 | -0.004 | -0.14 | -0 | -0.7 | -0.66 | -0.58 | -0.37 | -1.14 |
| EBITDA
| 66.332 | 72.486 | 27.408 | 58.157 | 46.321 | 70.615 | 52.966 | 46.487 | 53.681 | 17.964 | 39.171 | 32.755 | 33.391 | -0.361 | 28.041 | 19.212 | 12.141 | 10.822 | 9.313 | -7.726 | -31.748 | -28.751 | -19.14 | -63.054 |
| EBITDA Ratio
| 0.33 | 0.39 | 0.159 | 0.376 | 0.364 | 0.441 | 0.349 | 0.39 | 0.372 | 0.154 | 0.366 | 0.384 | 0.314 | 0.643 | 0.38 | 0.322 | 0.138 | 0.237 | 0.245 | 0.752 | -5.296 | 0 | 0 | 0 |